Inventor · disambiguated record
Andrew R. Blight
Also filed as: BLIGHT ANDREW · BLIGHT ANDREW R
11 granted patents·57 pending applications·90 citations·filing 1993–2023
90Inventor score
Files withACORDA THERAPEUTICS INC47BLIGHT ANDREW R12ECHOSTAR UK HOLDINGS LTD2WESSEL THOMAS C2BLIGHT ANDREW1
Top patents by PatentIndex Score
68 records- 0194US8007826B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2004·Granted Aug 30, 2011·29 cites·41 claims
- 0292US8354437B2Method of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2005·Granted Jan 15, 2013·13 cites·40 claims
- 0390US2023390261A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0489US8440703B2Methods of using sustained release aminopyridine compositionsBLIGHT ANDREW R·Filed 2011·Granted May 14, 2013·9 cites·52 claims
- 0588US8663685B2Sustained release aminopyridine compositionBLIGHT ANDREW R·Filed 2011·Granted Mar 4, 2014·5 cites·8 claims
- 0688US2023133230A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0785US2022296577A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0884US2024041850A1Methods of Using Sustained Release Aminopyridine CompositionsACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0983US2022040161A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1080US2021205282A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1178US2020113883A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1278US2020113882A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1377US2020368217A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1475US2019022076A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1575US2019247379A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1674US2018153869A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1774US2019314350A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1873US9918973B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·0 cites·12 claims
- 1973US2019015399A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2073US2019000820A1Durable Treatment with 4-Aminopyridine in Patients with DemyelinationACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2173US2021251974A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2272US2014206728A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2371US2021008051A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2470US2013310426A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2569US5545648AUse of 4-aminopyridine in the reduction of chronic pain and spasticity in a spinal cord injured patientCANADIAN SPINAL RES ORG·Filed 1993·Granted Aug 13, 1996·34 cites·5 claims
- 2669US2017281608A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2769US2017266171A1Durable Treatment with 4-Aminopyridine in Patients with DemyelinationACORDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2868US2019247378A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2968US2020171012A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3068US2018200241A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3168US2015080436A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3267US9925173B2Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2017·Granted Mar 27, 2018·0 cites·29 claims
- 3367US2017035742A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3467US2017056385A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3566US2016213661A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3666US2016184286A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3765US2017071924A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3865US2014039015A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3965US2018147193A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4064US2010061935A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 4163US2016199358A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4261US2010324098A1Sustained release aminopyridine compositionsBLIGHT ANDREW R·Filed 2010·Application pending·0 cites
- 4361US2010324099A1Sustained release aminopyridine compositionsBLIGHT ANDREW R·Filed 2010·Application pending·0 cites
- 4461US2010324100A1Sustained release aminopyridine compositionsBLIGHT ANDREW R·Filed 2010·Application pending·0 cites
- 4561US2012164078A1Methods of using sustained release aminopyridine compositionsBLIGHT ANDREW R·Filed 2012·Application pending·0 cites
- 4660US2013267566A1Durable treatment with 4-aminopyridine in patients with demyelinationBLIGHT ANDREW R·Filed 2010·Application pending·0 cites
- 4759US2018277256A1Method, apparatus and software for identifying responders in a clinical environmentACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4858US2020016247A1Compositions and methods for the treatment of cns injuriesACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4958US2015313886A1Compositions and methods for extended therapy with aminopyridinesACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5057US8942538B2Apparatus, systems and methods for storing program events in an enhanced history bufferELDON TECHNOLOGY LTD·Filed 2012·Granted Jan 27, 2015·0 cites·11 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →